Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurie Menger

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Methods in Enzymology|January 18, 2020
Methods to edit T cells for cancer immunotherapyFrancesca Lucibello, Silvia Menegatti, Laurie Menger
STAR Protocols|December 14, 2022
Optimized protocol to generate genome-wide inactivated Cas9-expressing murine T cellsMarguerite Laprie-Sentenac, Clara Cretet-Rodeschini, Laurie Menger
Trends in Cancer|April 10, 2026
Epigenetic, epitranscriptomic, and metabolic control of T cell exhaustionChloe Slater, Albane Simon, Marguerite Laprie-Sentenac, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2010
Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathwayLaurence Zitvogel, Oliver Kepp, Laura Senovilla, et al.
Molecular Oncology|November 19, 2015
Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapyAnna Śledzińska, Laurie Menger, Katharina Bergerhoff, et al.
Oncoimmunology|March 26, 2013
Trial watch: Cardiac glycosides and cancer therapyLaurie Menger, Erika Vacchelli, Oliver Kepp, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Quantification of cell cycle-arresting proteinsOliver Kepp, Isabelle Martins, Laurie Menger, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 5, 2013
Fluorescent biosensors for the detection of HMGB1 releaseIsabelle Martins, Oliver Kepp, Laurie Menger, et al.
Annals of the New York Academy of Sciences|October 21, 2010
Surface-exposed calreticulin in the interaction between dying cells and phagocytesIsabelle Martins, Oliver Kepp, Lorenzo Galluzzi, et al.
Cancer Metastasis Reviews|January 21, 2011
Molecular determinants of immunogenic cell death elicited by anticancer chemotherapyOliver Kepp, Lorenzo Galluzzi, Isabelle Martins, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Methods in Enzymology|January 18, 2020
Methods to edit T cells for cancer immunotherapyFrancesca Lucibello, Silvia Menegatti, Laurie Menger
STAR Protocols|December 14, 2022
Optimized protocol to generate genome-wide inactivated Cas9-expressing murine T cellsMarguerite Laprie-Sentenac, Clara Cretet-Rodeschini, Laurie Menger
Trends in Cancer|April 10, 2026
Epigenetic, epitranscriptomic, and metabolic control of T cell exhaustionChloe Slater, Albane Simon, Marguerite Laprie-Sentenac, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2010
Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathwayLaurence Zitvogel, Oliver Kepp, Laura Senovilla, et al.
Molecular Oncology|November 19, 2015
Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapyAnna Śledzińska, Laurie Menger, Katharina Bergerhoff, et al.
Oncoimmunology|March 26, 2013
Trial watch: Cardiac glycosides and cancer therapyLaurie Menger, Erika Vacchelli, Oliver Kepp, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Quantification of cell cycle-arresting proteinsOliver Kepp, Isabelle Martins, Laurie Menger, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 5, 2013
Fluorescent biosensors for the detection of HMGB1 releaseIsabelle Martins, Oliver Kepp, Laurie Menger, et al.
Annals of the New York Academy of Sciences|October 21, 2010
Surface-exposed calreticulin in the interaction between dying cells and phagocytesIsabelle Martins, Oliver Kepp, Lorenzo Galluzzi, et al.
Cancer Metastasis Reviews|January 21, 2011
Molecular determinants of immunogenic cell death elicited by anticancer chemotherapyOliver Kepp, Lorenzo Galluzzi, Isabelle Martins, et al.
Pageof 3